Carisoprodol
Carbamic Acid Esters
- Drug class
- Carbamic Acid Esters
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 3
- FDA reports (12 mo)
- 147
Overview
Plain-language summary, compiled from the cited regulatory records
Carisoprodol is a medication belonging to the carbamic acid ester drug class [1]. It is approved for adults to relieve discomfort associated with acute, painful musculoskeletal conditions [1].
Carisoprodol is intended for short-term use, typically two to three weeks. This limitation is due to a lack of established effectiveness for longer periods and the generally short duration of acute, painful musculoskeletal conditions [1].
In the past 12 months, there have been 147 adverse event reports associated with carisoprodol [2]. Common reasons cited in these reports include off-label use, nausea, upper abdominal pain, diarrhea, and the perception of the drug being ineffective [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 3 | February 27, 2026 |
USUnited States· FDA
3 products
Uses
1 INDICATIONS AND USAGE Carisoprodol is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Limitation of Use Carisoprodol should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration.
[ see Dosage and Administration (2) ]. Carisoprodol is a muscle relaxant indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. (1) Limitations of Use Should only be used for acute treatment periods up to two or three weeks ( 1 )
How to take
Drug interactions
Known interactions involving Carisoprodol. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 503. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 03c3455f-e217-4a… · revised December 24, 2024 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.